186 related articles for article (PubMed ID: 20041330)
1. Effects of atypical (risperidone) and typical (haloperidol) antipsychotic agents on astroglial functions.
Quincozes-Santos A; Bobermin LD; Tonial RP; Bambini-Junior V; Riesgo R; Gottfried C
Eur Arch Psychiatry Clin Neurosci; 2010 Sep; 260(6):475-81. PubMed ID: 20041330
[TBL] [Abstract][Full Text] [Related]
2. Atypical neuroleptic risperidone modulates glial functions in C6 astroglial cells.
Quincozes-Santos A; Bobermin LD; Kleinkauf-Rocha J; Souza DO; Riesgo R; Gonçalves CA; Gottfried C
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):11-5. PubMed ID: 19013209
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of typical and atypical antipsychotics on astroglial cells in vitro.
Bobermin LD; da Silva A; Souza DO; Quincozes-Santos A
Int J Dev Neurosci; 2018 Oct; 69():1-9. PubMed ID: 29902518
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients.
Smesny S; Langbein K; Rzanny R; Gussew A; Burmeister HP; Reichenbach JR; Sauer H
Schizophr Res; 2012 Jul; 138(2-3):164-70. PubMed ID: 22516552
[TBL] [Abstract][Full Text] [Related]
5. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.
Pillai A; Parikh V; Terry AV; Mahadik SP
J Psychiatr Res; 2007 Aug; 41(5):372-86. PubMed ID: 16564057
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone.
de Souza DF; Wartchow K; Hansen F; Lunardi P; Guerra MC; Nardin P; Gonçalves CA
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():14-22. PubMed ID: 23246638
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia.
Miller DD; Andreasen NC; O'Leary DS; Watkins GL; Boles Ponto LL; Hichwa RD
Biol Psychiatry; 2001 Apr; 49(8):704-15. PubMed ID: 11313038
[TBL] [Abstract][Full Text] [Related]
8. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of the antipsychotics haloperidol and clozapine on G protein measures in mononuclear leukocytes of patients with schizophrenia.
Avissar S; Roitman G; Schreiber G
Cell Mol Neurobiol; 2001 Dec; 21(6):799-811. PubMed ID: 12043849
[TBL] [Abstract][Full Text] [Related]
10. Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats.
Fell MJ; Neill JC; Marshall KM
Eur Neuropsychopharmacol; 2004 Oct; 14(5):385-92. PubMed ID: 15336300
[TBL] [Abstract][Full Text] [Related]
11. Lipoic acid increases glutamate uptake, glutamine synthetase activity and glutathione content in C6 astrocyte cell line.
Kleinkauf-Rocha J; Bobermin LD; Machado Pde M; Gonçalves CA; Gottfried C; Quincozes-Santos A
Int J Dev Neurosci; 2013 May; 31(3):165-70. PubMed ID: 23286972
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
Markianos M; Hatzimanolis J; Lykouras L
Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
[TBL] [Abstract][Full Text] [Related]
13. Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia.
Zhang XY; Zhou DF; Shen YC; Zhang PY; Zhang WF; Liang J; Chen DC; Xiu MH; Kosten TA; Kosten TR
Neuropharmacology; 2012 Apr; 62(5-6):1928-34. PubMed ID: 22227558
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.
Basson BR; Kinon BJ; Taylor CC; Szymanski KA; Gilmore JA; Tollefson GD
J Clin Psychiatry; 2001 Apr; 62(4):231-8. PubMed ID: 11379836
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
J Pharmacol Exp Ther; 2000 Apr; 293(1):8-14. PubMed ID: 10734147
[TBL] [Abstract][Full Text] [Related]
16. Acute phase of schizophrenia: impact of atypical antipsychotics.
Azorin JM
Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S5-9. PubMed ID: 11252521
[TBL] [Abstract][Full Text] [Related]
17. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
Gardell LR; Vanover KE; Pounds L; Johnson RW; Barido R; Anderson GT; Veinbergs I; Dyssegaard A; Brunmark P; Tabatabaei A; Davis RE; Brann MR; Hacksell U; Bonhaus DW
J Pharmacol Exp Ther; 2007 Aug; 322(2):862-70. PubMed ID: 17519387
[TBL] [Abstract][Full Text] [Related]
18. Insight in persons with schizophrenia: effects of switching from conventional neuroleptics to atypical antipsychotics.
Aguglia E; De Vanna M; Onor ML; Ferrara D
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1229-33. PubMed ID: 12502008
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
J Clin Psychiatry; 2004 Jul; 65(7):940-7. PubMed ID: 15291683
[TBL] [Abstract][Full Text] [Related]
20. Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum.
Gruber SH; Mathé AA
J Neurosci Res; 2000 Aug; 61(4):458-63. PubMed ID: 10931533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
